Sign In

Home

Learning Destinations

ACC.10 Expo

Atlanta

CardioSource News

Press Room

Educational Satellite Symposia

Grantor Acknowledgements

Presenters Only

Exhibitors Only

Media Only

Contact Us

About ACC

Education Highlights

 

Cutting-edge Keynote Lectures

 

Don't miss your chance to see these cutting-edge keynote lectures during ACC.10 and i2 Summit.

  • Anthony Atala, M.D., will present the annual Simon Dack Lecture duing the Scientific Showcase Session, taking place at 10:30 a.m. on Sunday, March 14. Don't miss this exciting lecture focusing on the future of medicine and regenerative medicine.
  • Richard M. Satava, M.D., F.A.C.S., presents the Louis F. Bishop Lecture with a focus on robotics, information technology and artificial intelligence in health care.
  • Jean-Pierre Bassand, M.D., F.A.C.C., will deliver the ninth annual Maseri-Florio International Lecture on Tuesday. The lecture will focus on improved outcomes in acute coronary syndromes (ACS) without excess bleeding.
  • The inaugural McNamara Lecture will honor the late Dan Goodrich McNamara, M.D., M.A.C.C. The lecture titled "Dan McNamara: Innovator, Collaborator and Clinician" will be presented by Charles E. Mullins, M.D., F.A.C.C.

Joint International Lunchtime Symposia

 

We’ve designed 15 joint sessions with international societies to meet the needs of clinicians in the host societies’ countries. Don’t miss this rare opportunity to meet and share ideas with respected leaders in cardiology from around the world.

  • Joint Session of the Canadian Society of Cardiology and the American College of Cardiology: Upstream Risk Factor Identification, Modification and Interventions in Atrial Fibrillation

  • Joint Session of the Turkish Society of Cardiology and the American College of Cardiology: International Perspectives on Heart Failure

  • Joint Session of the Italian Federation of Cardiology and the American College of Cardiology: Pregnancy and the Management of Adult Congenital Cardiology Patients

  • Joint Session of the Latin American Southern Cones Countries and the American College of Cardiology: A Focus on Tetralogy of Fallot

  • Joint Session of the Japanese College of Cardiology and the American College of Cardiology: Genetics versus Lifestyle

  • Joint Session of the Chinese Society of Cardiology and the American College of Cardiology: Risk Factor Modification

  • Joint Session of the Russian Society of Cardiology and the American College of Cardiology: Behavioral Health Issues as Risk Factors for Cardiovascular Outcomes

  • Joint Session of the Gulf Heart Association and the American College of Cardiology: Outcomes in ACS

  • Joint Session of the Spanish Society of Cardiology and the American College of Cardiology: Management of Coronary Artery Disease in the Elderly

  • Joint Session of the Israel Heart Society and the American College of Cardiology: Future Treatments

  • Joint Session of the Brazilian Society of Cardiology and the American College of Cardiology: Treating the Microcirculation

  • Joint Session of the German Cardiac Society and the American College of Cardiology: Contemporary Issues in Antithrombotic Therapy

  • Joint Session of the Cardiological Society of India and the American College of Cardiology: Contemporary Issues in Rheumatic Heart Disease and Endocarditis

  • Joint Session of the Malaysian Heart Association and the American College of Cardiology: The Mitral Valve

  • Joint Session of the Mexican Society of Cardiology and the American College of Cardiology: Vascular Disease Across the Border

Late-Breaking Clinical Trials

 

Late-Breaking Clinical Trials for presentation at ACC.10 and i2 Summit have been selected! The impressive line-up of cutting-edge science includes the results of EVEREST II, comparing percutaneous repair of mitral valve leakage to surgical repair; the STOP-AF trial of cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation; and a five-year follow-up of the PASSION Trial of Paclitaxel-eluting stents vs. bare-metal stents. Don’t miss these trials and more.

 

Late-Breaking Clinical Trials I: General Cardiology

Session 3010

ACC/i2 Joint Session

Sunday, Mar 14, 2010, 8:00 a.m. – 9:30 a.m.

Georgia World Congress Center, Murphy Ballroom

 

  • Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The ACCORD Lipid Study
  • Effects of Intensive Blood Pressure Control on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial
  • Rethinking Lower BP Goals for Diabetics with Documented Coronary Artery Disease: Findings from the INternational VErapamil SR - Trandolapril STudy (INVEST)
  • The Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
  • 3010-14: Primary Safety and Efficacy Endpoints of the EVEREST II Randomized Clinical Trial

Late-Breaking Clinical Trials II: Cardiac Arrhythmias

Session 3015

ACC/i2 Joint Session

Monday, Mar 15, 2010, 8:00 a.m. – 9:30 a.m.

Georgia World Congress Center, Murphy Ballroom

 

  • Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation: First Results of the North American Arctic Front Stop-AF Clinical Trial
  • Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison Between Lenient Versus Strict Rate Control in Patients With and Without Heart Failure. The RACE II Study
  • The Impact of Remote Monitoring with Automatic Clinician Notifications on the clinical care of ICD and CRT-D Patients
  • A Randomized Clinical Trial of Three Doses of a Long-Acting Oral Direct Factor Xa Inhibitor Betrixaban in Patients with Atrial Fibrillation
  • Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation: First Results of the CABANA Pilot Study

Late-Breaking Clinical Trials III: Interventional Cardiology

Session 3016

ACC/i2 Joint Session

Monday, Mar 15, 2010, 10:30 a.m. – Noon

Georgia World Congress Center, Murphy Ballroom

 

  • Randomized All-comer Comparison of Zotarolimus-eluting and Sirolimus-eluting Coronary Stents: 18-month Follow-up in the SORT OUT III Trial
  • Randomized Trial of a Polymer-Free Dual Drug-Eluting Stent versus Polymer-Based Cypher and Endeavor Drug-Eluting Stents - Two-year Clinical and Angiographic Outcomes
  • First Report of the PERSEUS Randomized Controlled Trial Comparison of a Novel Platinum-Chromium, Thin-Strut TAXUS Element Stent Versus the TAXUS Express Stent in de novo Coronary Stenoses
  • Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications after Drug-eluting Stent Implantation for Coronary Heart Disease : Influence of Cilostazol-based triple anti-platelet therapy on Ischemic Complication after drug-eluting stent implantation (CILON-T) study
  • Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation: A Randomized, Multi-Center Trial

Late-Breaking Clinical Trials IV

Session 3019

ACC/i2 Joint Session

Tuesday, Mar 16, 2010, 8:00 a.m. – 9:30 a.m.

Georgia World Congress Center, Murphy Ballroom

 

  • Effect of Genotyping Warfarin Patients on Outcomes: Results from The National Community-based Medco-Mayo Warfarin Effectiveness Study (MM-WES)
  • The Diuretic Optimization Strategies Evaluation (DOSE) Study: A Randomized, Double Blind, Placebo-controlled Trial Of Diuretic Strategies In Acute Decompensated Heart Failure
  • Effect of the Direct Renin Inhibitor Aliskiren on Left Ventricular Remodeling Following Myocardial Infarction with Left Ventricular Dysfunction: ASPIRE
  • Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction: A Propensity Score-Matched Analysis
  • Influence of Reduction of Left Ventricular Volume on Outcome After Coronary Artery Bypass Grafting With or Without Surgical Ventricular Reconstruction

Late-Breaking Clinical Trials V: Interventional Cardiology

Session 3020

ACC/i2 Joint Session

Tuesday, Mar 16, 2010, 10:30 a.m. – Noon

Georgia World Congress Center, Murphy Ballroom

  • Randomized Comparison of Angiojet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting to Direct Stenting Alone in Patients with Acute Myocardial Infarction: the Jetstent Trial
  • Long-term Outcome after Drug-Eluting versus Bare-Metal Stent Implantation in Patients with ST-Elevation Myocardial Infarction. Three-year follow-up of the DEDICATION Trial
  • Five Year Follow-up After Primary Percutaneous Coronary Intervention With A Paclitaxel-eluting Stent Versus A Bare-metal Stent In Acute ST-segment Elevation Myocardial Infarction. A Follow-up Study Of The PASSION-Trial
  • Ticagrelor Versus Clopidogrel In Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: Results From The PLATO Trial
  • A Randomized Trial Radial Artery Grafts versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery: VA Cooperative Study

 

Be sure to also attend the new “Trialist Is In” round-table sessions where you’ll get to meet-and-greet the trialists and ask questions in an informal setting, Sunday and Monday, from 3:30 p.m. – 4:30 p.m. in Hall B2.

 

Click here to use the program planner to search and browse these sessions and more.